215 related articles for article (PubMed ID: 25911000)
1. Primary hyperparathyroidism and nephrolithiasis.
Vestergaard P
Ann Endocrinol (Paris); 2015 May; 76(2):116-9. PubMed ID: 25911000
[TBL] [Abstract][Full Text] [Related]
2. Nephrolithiasis and renal calcifications in primary hyperparathyroidism.
Rejnmark L; Vestergaard P; Mosekilde L
J Clin Endocrinol Metab; 2011 Aug; 96(8):2377-85. PubMed ID: 21646371
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Renal Function and Calcifications in Primary Hyperparathyroidism: A Nested Case-Control Study.
Ejlsmark-Svensson H; Bislev LS; Rolighed L; Sikjaer T; Rejnmark L
J Clin Endocrinol Metab; 2018 Sep; 103(9):3574-3583. PubMed ID: 29955845
[TBL] [Abstract][Full Text] [Related]
4. Patients with primary hyperparathyroidism--why do some form stones?
Berger AD; Wu W; Eisner BH; Cooperberg MR; Duh QY; Stoller ML
J Urol; 2009 May; 181(5):2141-5. PubMed ID: 19296981
[TBL] [Abstract][Full Text] [Related]
5. Hypomagnesuria is Associated With Nephrolithiasis in Patients With Asymptomatic Primary Hyperparathyroidism.
Saponaro F; Marcocci C; Apicella M; Mazoni L; Borsari S; Pardi E; Di Giulio M; Carlucci F; Scalese M; Bilezikian JP; Cetani F
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32369583
[TBL] [Abstract][Full Text] [Related]
6. Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
Cong X; Shen L; Gu X
Urolithiasis; 2018 Oct; 46(5):453-457. PubMed ID: 29350243
[TBL] [Abstract][Full Text] [Related]
7. Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?
Saponaro F; Cetani F; Mazoni L; Apicella M; Di Giulio M; Carlucci F; Scalese M; Pardi E; Borsari S; Bilezikian JP; Marcocci C
J Endocrinol Invest; 2020 May; 43(5):677-682. PubMed ID: 31873910
[TBL] [Abstract][Full Text] [Related]
8. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism.
Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML
Surgery; 2012 Mar; 151(3):477-83. PubMed ID: 21893327
[TBL] [Abstract][Full Text] [Related]
9. [Recurrent episodes of brushite nephrolithiasis revealing primary hyperparathyroidism].
Simon I; Roumeguère T; Devuyst F; Cotton F; Tang BN; Cappello M; Corbetta S; Idrissi M; Pozdzik A; Nortier J
Rev Med Brux; 2015; 36(3):172-6. PubMed ID: 26372980
[TBL] [Abstract][Full Text] [Related]
10. [Renal function in primary hyperparathyroidism].
Borretta G; Gianotti L; Cesario F; Borretta V; Tassone F
G Ital Nefrol; 2010; 27 Suppl 50():S91-5. PubMed ID: 20922703
[TBL] [Abstract][Full Text] [Related]
11. Primary hyperparathyroidism.
Oberger Marques JV; Moreira CA
Best Pract Res Clin Rheumatol; 2020 Jun; 34(3):101514. PubMed ID: 32336576
[TBL] [Abstract][Full Text] [Related]
12. Nephrocalcinosis: re-defined in the era of endourology.
Miller NL; Humphreys MR; Coe FL; Evan AP; Bledsoe SB; Handa SE; Lingeman JE
Urol Res; 2010 Dec; 38(6):421-7. PubMed ID: 21057942
[TBL] [Abstract][Full Text] [Related]
13. Metaphylaxis of nephrolithiasis.
Jacobellis U
Urol Int; 2007; 79 Suppl 1():51-5. PubMed ID: 17726353
[TBL] [Abstract][Full Text] [Related]
14. Screening for asymptomatic nephrolithiasis in primary hyperparathyroidism patients is warranted.
Zabolotniuk T; Guo M; Kwon M; Watanabe A; Teichman JMH; Wiseman SM
Am J Surg; 2024 May; 231():91-95. PubMed ID: 38480062
[TBL] [Abstract][Full Text] [Related]
15. NEPHROLITHIASIS IN PRIMARY HYPERPARATHYROIDISM: A COMPARISON BETWEEN SILENT AND SYMPTOMATIC PATIENTS.
Castellano E; Attanasio R; Latina A; Visconti GL; Cassibba S; Borretta G
Endocr Pract; 2017 Feb; 23(2):157-162. PubMed ID: 27819765
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology and diagnosis of nephrocalcinosis].
Fuster D
Ther Umsch; 2007 May; 64(5):287-90. PubMed ID: 17685089
[TBL] [Abstract][Full Text] [Related]
17. Urinary parameters as predictors of primary hyperparathyroidism in patients with nephrolithiasis.
Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML
J Urol; 2012 Feb; 187(2):516-21. PubMed ID: 22177167
[TBL] [Abstract][Full Text] [Related]
18. End-organ effects of primary hyperparathyroidism: A population-based study.
Assadipour Y; Zhou H; Kuo EJ; Haigh PI; Adams AL; Yeh MW
Surgery; 2019 Jan; 165(1):99-104. PubMed ID: 30420089
[TBL] [Abstract][Full Text] [Related]
19. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
Parks JH; Coe FL; Evan AP; Worcester EM
BJU Int; 2009 Mar; 103(5):670-8. PubMed ID: 18793297
[TBL] [Abstract][Full Text] [Related]
20. Nephrolithiasis.
Worcester EM; Coe FL
Prim Care; 2008 Jun; 35(2):369-91, vii. PubMed ID: 18486720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
